SINGAPORE (Feb 16): Singapore O&G, the company specialising in women’s healthcare, announced a 64.8% rise in FY16 earnings to $8.8 million from $3.5 million a year ago.
Total revenue increased by 74.7% to $28.7 million largely due to the revenue contribution of $8.5 million from its new Dermatology segment (SOG Dermatology clinic), and increase in patient loads from its Obstetrics & Gynaecology (O&G) and cancer-related segments. O&G segment continues to be the highest contributor, at 60.9%, to the group’s revenue.
Singapore O&G says the republic continues to be challenged in its efforts to increase birth numbers, largely due to uncertainties in the local and global economies.
In FY16, it delivered 1,728 healthy babies, an increase of 5.8% compared to FY15. Singapore O&G’s market share in the private sector increased to 7.5% in FY16 from 6.7% in FY15.
Singapore O&G has declared a final tax exempt dividend of 1.57 cents per share.
Together with an interim dividend of 1.53 cents per share which was paid on Sept 1 2016, the 3.1 cents will constitute 83.9% of FY16 earnings, 52.7% higher compared to FY15.
Shares of Singapore O&G closed 2 cents lower at $1.32.
